Neurologie [Neurology]

Details

Serval ID
serval:BIB_AA0B8A9F29AA
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Title
Neurologie [Neurology]
Journal
Revue medicale suisse
Author(s)
Chopard I., Benninger D., Demonet J.F., Du Pasquier R., Hirt L., Kuntzer T., Michel P., Nater B., Novy J., Rossetti A., Rouaud O., Ryvlin P., Schluep M., Theaudin M.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
10/01/2018
Peer-reviewed
Oui
Volume
14
Number
588-589
Pages
58-61
Language
french
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Ocrelizumab (Ocrevus), an anti-CD20 monoclonal antibody, has been approved for the treatment of multiple sclerosis. Eculizumab (Soliris) has been approved in several countries for refractory forms of generalized seropositive severe myasthenia gravis. A form of gene therapy, patisiran, has shown positive results in transthyretin familial amyloidosis. In the treatment of headaches, particularly migraines, non-pharmacological approaches have shown some interesting results. The criteria for Lewy body dementia have been revised. Generic use of lamotrigine does not result in recrudescence of epileptic seizures or adverse effects.
Keywords
Amyloid Neuropathies, Familial/drug therapy, Humans, Myasthenia Gravis/drug therapy, Neurology/trends, Prealbumin/therapeutic use, Rituximab/therapeutic use
Pubmed
Create date
24/01/2018 12:44
Last modification date
14/05/2019 6:11
Usage data